Remove Chemotherapy Remove Compounding Remove Controlled Substances Remove FDA
article thumbnail

How to explain CBD vs. marijuana to patients

The Checkup by Singlecare

Understanding the difference between CBD vs. marijuana Cannabinoids are compounds found in the cannabis plant, Cannabis sativa. The United States Congress legalized CBD derived from hemp in 2018 when the Agricultural Improvement Act was signed into law, removing hemp from the Federal Controlled Substances Act.

article thumbnail

Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled

The FDA Law Blog

Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. By Larry K. 53,688 (Aug. 53,767 (Aug. 21 U.S.C. §

FDA 69
article thumbnail

Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not

The FDA Law Blog

FDA has not approved marijuana for medical use because no double-blind, published studies show safety and efficacy for raw marijuana. In other words, no rescheduling. There has been no evidence that marijuana’s schedule should change since the last rescheduling review in 2016.